Regulation of transcription of the human MRP7 gene. Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5′ end heterogeneity

Gene

Volumn 341, Issue 1-2, 2004, Pages 129-139

  Dabrowska, Magdalena ^a,b   Sirotnak, Francis M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

ABC; ATP binding cassette; electromobility shift assay; EMSA; MDR; membrane spanning domain 2; MRP; MRP7 promoter and splicing; MSD2; multidrug resistance; Multidrug Resistance Protein; multidrug resistance associated protein; RACE

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 7; OLIGONUCLEOTIDE; PROTEIN ANTIBODY; PROTEIN P107; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F5; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DNA MICROARRAY; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC HETEROGENEITY; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR CELL CULTURE;

5' FLANKING REGION; 5' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MICE; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; NIH 3T3 CELLS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE PROBES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN ISOFORMS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 5044228351     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2004.06.022     Document Type: Article

References (40)

1. Ambudkar S.V., Kimchi-Sarfaty C., Sauna Z.E., Gottesman M.M. P-glycoprotein: from genomics to mechanism. Oncogene. 22:2003;7468-7485
2. Borst P., Schinkel A.H. Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet. 13:1997;217-222
3. Borst P., Evers R., Kool M., Wijnholds J. The multidrug resistance protein family. Biochim. Biophys. Acta. 1461:1999;347-357
4. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:2000;1295-1302
5. Blake M.C., Jambou R.C., Swick A.G., Kahn J.W., Azizkhan J.C. Transcription initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol. Cell. Biol. 10:1990;6632-6641
6. Chen X., Prywes R. Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression. Mol. Cell. Biol. 19:1999;4695-4702
7. Chen Z.-S., Hopper-Borge E., Belinsky M.G., Shchaveleva I., Kotova E., Kruh G.D. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol. Pharmacol. 63:2003;351-358
8. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654
9. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489
10. Englert C., Hou X., Maheswaran S., Bennett P., Ngwu C., Re G.R., Garvin A.J., Rosner M.R., Haber D.A. WT1 suppresses synthesis of the epidermal growth receptor and induces apoptosis. EMBO J. 14:1995;4662-4675
11. Ge Y.-W., Maloney B., Sambamurti K., Lahia D.K. Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. FASEB J. 2004;. (published on line)
12. German U.A. P-glycoprotein-a mediator of multidrug resistance in tumor cells. Eur. J. Cancer. 32A:1996;927-944
13. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Kolpakov F.A., Podkolodny N.L., Kolchanov N.A. Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucleic Acids Res. 26:1998;364-370
14. Hipfner D.R., Deeley R.G., Cole S.P.C. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta. 1461:1999;359-376
15. Hopper E., Belinsky M.G., Zeng H., Tosolini A., Testa J.R., Kruh G.D. Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett. 162:2001;181-191
16. Huang D., Jokela M., Tuusa J., Skog S., Poikonen K., Syvaoja J.E. E2F mediates induction of the Sp1-controlled promoter of the human DNA polymerase ε B-subunit gene POLE2. Nucleic Acids Res. 29:2001;2810-2821
17. Kaneda S., Nalbantoglu J., Takeishi K., Schimizu K., Gotoh O., Seno T., Ayusawa D. Structural and functional analysis of the human thymidylate synthase gene. J. Biol. Chem. 265:1990;20277-20284
18. Kao H., Chang M., Cheng J., Huang J. Genomic structure, gene expression, and promoter analysis of human multidrug resistance-associated protein 7. J. Biomed. Sci. 10:2003;98-110
19. Khokhar N.Z., She Y., Rusch V.W., Sirotnak F.M. Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums. Clin. Cancer Res. 7:2001;3199-3205
20. Klein I., Sarkadi B., Varadi A. An inventory of the human ABC proteins. Biochim. Biophys. Acta. 1461:1999;237-262
21. Konig J., Nies A.T., Cui Y., Leier I., Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim. Biophys. Acta. 1461:1999;377-394
22. Kurz E.U., Cole S.P.C., Deeley R.G. Identification of DNA-protein interactions in the 5′ flanking and untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. Biochem. Biophys. Res. Commun. 285:2001;981-990
23. Lee S.B., Haber D.A. Wilms tumor and the WT1 gene. Exp. Cell Res. 264:2001;74-99
24. Lin S.-Y., Black A.R., Kostic D., Pajovic S., Hoover C.N., Azizkhan J.C. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell. Biol. 16:1996;1668-1675
25. Rotheneder H., Geymayer S., Haidweger E. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. J. Mol. Biol. 293:1999;1005-1015
26. Samuels L.L., Moccio D.M., Sirotnak F.M. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro. Cancer Res. 45:1985;1488-1495
27. Schug, J., Overton, G.C., 1998. TESS: transcription element search software on the WWW. Biol Informatics Lab, School of Medicine, Univ. Pennsylvania, 1998. URL: http://avage.humgen.upenn.edu/utess/tess (unpublished).
28. Smale S.T. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta. 1351:1997;73-88
29. Stevens C., La Thangue N.B. E2F and cell cycle: a double-edged sword. Arch. Biochem. Biophys. 412:2003;157-169
30. Stockel B., Konig J., Nies A.T., Cui Y., Brom M., Keppler D. Characterization of the 5′-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison with the multidrug resistance protein 3 (MRP3) gene. Eur. J. Biochem. 267:2000;1347-1358
31. Sullivan G.F., Yang J.-M., Vassil A., Yang J., Bash-Babula J., Hait W.N. Regulation of expression of the multidrug resistance protein MRP1 by p53 in human cancer cells. J. Clin. Invest. 105:2000;1261-1267
32. Takada T., Suzuki H., Sugiyama Y. Characterization of 5′-flanking region of human MRP3. Biochem. Biophys. Res. Commun. 270:2000;728-732
33. Tintrup H., Fischer M., Betz H., Kuhse J. Exonic Sp1 sites are required for neural-specific expression of the glycine receptor β subunit gene. Biochem. J. 355:2001;179-187
34. Tommasi S., Pfeifer G.P. In vivo structure of the human cdc2 gene promoter: release of a p130 E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15:1995;6901-6913
35. Tanaka T., Uchiumi T., Hinoshita E., Inokuchi A., Toh S., Wada M., Takano H., Kohno K., Kuwano M. The human multidrug resistance protein 2 gene: functional characterization of the 5′-flanking region and expression in hepatic cells. Hepatology. 30:1999;1507-1512
36. Tsang W.-P., Chau S.P.Y., Fung K.-P., Kong S.-K., Kwok T.-T. Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells. Cancer Chemother. Pharmacol. 51:2003;161-166
37. Wang Q., Beck W.T. Transcriptional suppression of multidrug resistance associated protein (MRP1) gene expression by wild-type p53. Cancer Res. 58:1998;14517-14522
38. Young L.C., Campling B.G., Voskoglou-Nomikos T., Cole S.P.C., Deeley R.G., Gerlach J.H. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin. Cancer Res. 5:1999;673-680
39. Zenzie-Gregory B., Khachi A., Garraway I.P., Smale S.T. Mechanism of initiator-mediated transcription: evidence for a functional interaction between TATA-binding protein and DNA in the absence of a specific recognition sequence. Mol. Cell. Biol. 13:1993;3841-3849
40. Zhu Q., Center M.S. Evidence that Sp1 modulates transcriptional activity of the multidrug resistance-associated protein gene. DNA Cell Biol. 15:1996;105-111